Children with sickle cell disease: Growth and gonadal function after hematopoietic stem cell transplantation

Journal of Pediatric Hematology/Oncology

Volumn 29, Issue 7, 2007, Pages 445-450

  Brachet, Cécile ^a   Heinrichs, Claudine ^a   Tenoutasse, Sylvie ^a   Devalck, Christine ^a   Azzi, Nadira ^a   Ferster, Alina ^a  

^a HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

Author keywords

BMT conditioning; Busulphan; Cyclophosphamide; Gonadal function; Sickle cell disease

Indexed keywords

AZATHIOPRINE; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ESTROGEN; ETHINYLESTRADIOL; FOLLITROPIN; HYDROXYUREA; LUTEINIZING HORMONE; METHOTREXATE; STEROID; TESTOSTERONE; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; AMENORRHEA; ARTICLE; AZOOSPERMIA; BONE MARROW TRANSPLANTATION; CELL DAMAGE; CHILD; CHILD DEVELOPMENT; CHILD GROWTH; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DOSE RESPONSE; ESTROGEN THERAPY; FEMALE; FOLLITROPIN BLOOD LEVEL; GERM LAYER; GONAD DEVELOPMENT; GONAD DYSFUNCTION; GONAD FUNCTION; GONADOTROPIN BLOOD LEVEL; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HORMONE DETERMINATION; HUMAN; LEYDIG CELL; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MENSTRUATION; OLIGOSPERMIA; OVARY DEVELOPMENT; OVARY FUNCTION; OVARY INSUFFICIENCY; PREGNANCY; PRIORITY JOURNAL; PUBERTY; REPRODUCTIVE TOXICITY; SICKLE CELL ANEMIA; SIDE EFFECT; TESTIS DEVELOPMENT; TESTIS SIZE; TESTOSTERONE BLOOD LEVEL;

ADOLESCENT; ANEMIA, SICKLE CELL; BODY HEIGHT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLICLE STIMULATING HORMONE; GONADS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LONGITUDINAL STUDIES; MALE; PUBERTY;

EID: 34347371274     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e31806451ac     Document Type: Article

References (29)

1. Vermylen C, Fernandez-Robles E, Ninane J, et al. Bone marrow transplantation in five children with sickle cell anaemia. Lancet. 1988;1:1427-1428.
2. Louis J, Limarzi LR, Best WR. Treatment of chronic granulocytic leukaemia with myleran. Arch Intern Med. 1956;97:299.
3. Miller DG. Alkylating agents and human spermatogenesis. JAMA. 1971;217:1662.
4. Fairley KF, Barrie JU, Johnson W. Sterility and testicular atrophy related to cyclophocphamide therapy. Lancet. 1972;1:568.
5. Vergauwen P, Ferster A, Vlsamis J, et al. Primary ovarian failure after prepubertal marrow transplant in a girl. Lancet. 1994;343:125-126.
6. Walters MC, Storb R, Patience M, et al. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. Blood. 2000;95:1918-1924.
7. Siris ES, Leventhal BG, Vaitukaitis JL. Effects of childhood leukemia and chemotherapy on puberty and reproductive function in girls. N Engl J Med. 1976;294:1143-1146.
8. Liesner RJ, Leiper AD, Hann IM, et al. Late effects of intensive treatment for acute myeloid leukemia and myelodysplasia in childhood. J Clin Oncol. 1994;12:916-924.
9. Teinturier C, Hartmann O, Valteau-Couanet D, et al. Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure. Bone Marrow Transplant. 1998;22:989-994.
10. Thibaud E, Rodriguez-Macias K, Trivin C, et al. Ovarian function after bone marrow transplantation during childhood. Bone Marrow Transplant. 1998;21:287-290.
11. Afify Z, Shaw PJ, Clavano-Harding A, et al. Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan/cyclophosphamide. Bone Marrow Transplant. 2000;25:1087-1092.
12. Bakker B, Oostdijk W, Bresters D, et al. Disturbances of growth and endocrine function after busulphan-based conditioning for haematopoietic stem cell transplantation during infancy and childhood. Bone Marrow Transplant. 2004;33:1049-1056.
13. Sanders JE, Hawley J, Levy W, et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood. 1996;87:3045-3052.
14. Grigg AP, McLachlan R, Zaja J, et al. Reproductive status in longterm bone marrow transplant survivors receiving busulfan-cyclophosphamide (120 mg/kg). Bone Marrow Transplant. 2000;26:1089-1095.
15. Anserini P, Chiodi S, Spinelli S, et al. Semen analysis following allogeneic bone marrow transplantation. Additional data for evidence-based counselling. Bone Marrow Transplant. 2002;30:447-451.
16. De Sanctis V. Growth and puberty and its management in thalassaemia. Horm Res 2002;58(suppl 1):72-79. Review.
17. Li CK, Chik KW, Wong GW, et al. Growth and endocrine function following bone marrow transplantation for thalassemia major. Pediatr Hematol Oncol. 2004;21:411-419.
18. Brachet C, Azzi N, Demulder A, et al. Hydroxyurea treatment for sickle cell disease: impact on haematopoietic stem cell transplantation's outcome. Bone Marrow Transplant. 2004;33:799-803.
19. Freeman JV, Cole TJ, Chinn S, et al. Cross sectional stature and weight reference curves for the UK, 1990. Arch Dis Child. 1995;73:17-24.
20. Neely EK, Hintz RL, Wilson DM, et al. Normal ranges for immunochemiluminometric gonadotropin assays. J Pediatr. 1995;127:40-46.
21. Gee BE, Platt OS. Growth and development. In: Embury SH, Hebbel RP, Mohandas N, et al, eds. Sickle Cell Disease: Basic Principles and Clinical Practice. New York: Raven Press, Ltd; 1994:589-597.
22. Wingard JR, Plotnick LP, Freemer CS, et al. Growth in children after bone marrow transplantation: busulfan plus cyclophosphamide versus cyclophosphamide plus total body irradiation. Blood. 1992;79:1068-1073.
23. Cohen A, Rovelli A, Bakker B, et al. Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: a study by the Working Party for Late Effects-EBMT. Blood. 1999;93:4109-4115.
24. Sanders JE. The impact of marrow transplant preparative regimens on subsequent growth and development. Semin Hematol 1991;28:244-249.
25. Howell SJ, Radford JA, Adams JE, et al. The impact of mild Leydig cell dysfunction following cytotoxic chemotherapy on bone mineral density (BMD) and body composition. Clin Endocrinol (Oxf). 2000;52:609-616.
26. Howell SJ, Radford JA, Smets EM, et al. Fatigue, sexual function and mood following treatment for haematological malignancy: the impact of mild Leydig cell dysfunction. Br J Cancer. 2000;82:789-793.
27. Wagner AM, Beier K, Christen E, et al. Leydig cell injury as a consequence of an acute graft-versus-host reaction. Blood. 2005;105:2988-2990.
28. Wiger R, Hongslo JK, Evenson DP, et al. Effects of acetaminophen and hydroxyurea on spermatogenesis and sperm chromatin structure in laboratory mice. Reprod Toxicol. 1995;9:21-33.
29. Shin JH, Mori C, Shiota K. Involvement of germ cell apoptosis in the induction of testicular toxicity following hydroxyurea treatment. Toxicol Appl Pharmacol. 1999;155:139-149.